3-(2-cyclohexylmethyloxy-1,1'-biphenyl-5-yl)propionic acid | 222626-96-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(2-cyclohexylmethyloxy-1,1'-biphenyl-5-yl)propionic acid
• 英文别名: 3-[4-(Cyclohexylmethoxy)-3-phenylphenyl]propanoic acid
• CAS: 222626-96-2
• 化学式: C₂₂H₂₆O₃
• 分子量: 338.447
• InChiKey: FQDPQCJGJYNNCC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  Methyl 3-(2-cyclohexylmethyloxy-1,1'-biphenyl-5-yl)propionate 生成 3-(2-cyclohexylmethyloxy-1,1'-biphenyl-5-yl)propionic acid
  参考文献：
  名称：

  Biphenyl-5-alkanoic acid derivatives and use thereof

  摘要：

  由一般式I或其盐所代表的化合物，其中n是2或3的整数；R代表具有4个或4个碳原子的直链或支链饱和烷基基团，环戊基团，环己基团或类似物；Y代表羟基或氨基团；A代表氢原子，羟基，甲氧基，硝基团或类似物；Q代表氢原子或羟基或甲氧基团。它们可以配制成药物组合物，作为与IgE产生抑制剂或IgE抗体相关的过敏疾病的预防或治疗药剂。

  公开号：

  US06376546B1

文献信息

• Substituted phenylalkanoic acid derivatives and use thereof
  申请人：——

  公开号：US20040044258A1

  公开（公告）日：2004-03-04

  A compound represented by the formula (I) or a salt thereof: 1 wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R 1 (CH 2 ) k — (wherein k represents 0 or an integer of 1 to 3; R 1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R 1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.

  化合物的化学式为（I）或其盐： 其中n表示1到3的整数，R表示具有3到8个碳原子的烷基基团，由以下化学式表示的基团：R1(CH2)k—（其中k表示0或1到3的整数；R1表示具有3到7个碳原子的饱和环烷基基团或具有6到8个碳原子的饱和紧凑环烷基基团，基团R1可以被具有1到4个碳原子的较低烷基基团取代）等，Ar表示如萘-1-基团等的紧凑双环基团，具有对前列腺素和白三烯生成的抑制作用，对由这些脂质介质引起的各种炎症性疾病等的预防和/或治疗治疗有用。
• PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF
  申请人：MORITA Kohei

  公开号：US20100093819A1

  公开（公告）日：2010-04-15

  A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA 2 , and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].

  由以下一般式（1）表示的化合物或其盐，具有优越的抑制对4型PLA2的活性，因此具有前列腺素和/或白三烯产生抑制作用【X代表卤素原子、可能被取代的烷基或类似物，Y代表氢原子或可能被取代的烷基，Z代表氢原子或可能被取代的烷基】。
• BIPHENYL-5-ALKANOIC ACID DERIVATIVES AND USE THEREOF
  申请人：Asahi Kasei Kogyo Kabushiki Kaisha

  公开号：EP1024130A1

  公开（公告）日：2000-08-02

  Compounds represented by general formula (I) or salts thereof, wherein n is an integer of 2 or 3; R represents a straight-chain or branched saturated alkyl group having 4 or 5 carbon atoms, a cyclopentyl group, a cyclohexyl group or the like; Y represents a hydroxyl or amino group; A represents a hydrogen atom, a hydroxyl, methoxy, nitro group or the like; Q represents a hydrogen atom or a hydroxyl or methoxy group. They can be formulated to give pharmaceutical compositions that are effective as prophylactic or therapeutic agents for allergic diseases associated with IgE production inhibitors or IgE antibodies.

  由通式(I)代表的化合物或其盐类，其中n为2或3的整数；R代表具有4或5个碳原子的直链或支链饱和烷基、环戊基、环己基或类似基团；Y代表羟基或氨基；A代表氢原子、羟基、甲氧基、硝基或类似基团；Q代表氢原子或羟基或甲氧基。它们可以配制成药物组合物，作为预防或治疗与 IgE 生成抑制剂或 IgE 抗体相关的过敏性疾病的有效药物。
• SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF
  申请人：Asahi Kasei Pharma Corporation

  公开号：EP1477472A1

  公开（公告）日：2004-11-17

  A compound represented by the formula (I) or a salt thereof wherein n represents an integer of 1 to 3, R represents an alkyl group having 3 to 8 carbon atoms, a group represented by the following formula: R1(CH2)k- (wherein k represents 0 or an integer of 1 to 3; R1 represents a saturated cyclic alkyl group having 3 to 7 carbon atoms or a saturated condensed cyclic alkyl group having 6 to 8 carbon atoms, and the group R1 may be substituted with a lower alkyl group having 1 to 4 carbon atoms) and the like, and Ar represents a condensed bicyclic group such as naphthalen-1-yl group, which has suppressing action on prostaglandin and leukotriene production and is useful for prophylactic and/or therapeutic treatment of various inflammatory diseases and the like caused by these lipid mediators.

  由式（I）代表的化合物或其盐 其中 n 代表 1 至 3 的整数，R 代表具有 3 至 8 个碳原子的烷基，由下式代表的基团：R1(CH2)k- （其中 k 代表 0 或 1 至 3 的整数；R1 代表具有 3 至 7 个碳原子的饱和环状烷基或具有 6 至 8 个碳原子的饱和缩合环状烷基，该基团 R1 可被具有 1 至 4 个碳原子的低级烷基取代）等，Ar 代表缩合双环基团，例如萘-1-基团，该基团具有抑制前列腺素和白三烯生成的作用，可用于预防和/或治疗由这些脂质介质引起的各种炎症等。
• US6376546B1
  申请人：——

  公开号：US6376546B1

  公开（公告）日：2002-04-23